Atlas Trials

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Clinical trial NCT05625633 · RECRUITING

Trial details

NCT number
NCT05625633
Sponsor
Western Institute for Veterans Research
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Warts
Start date
2024-03-25
Primary completion
2025-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.